Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?

Urology. 2006 Nov;68(5):917-23. doi: 10.1016/j.urology.2006.06.013.

Authors

Raj S Pruthi¹, Erik Kouba, Culley C Carson 3rd, Eric M Wallen

Affiliation

¹ Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. rpruthi@med.unc.edu

PMID: 17113880
DOI: 10.1016/j.urology.2006.06.013

No abstract available

Publication types

Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Cardiovascular Diseases / chemically induced
Cyclooxygenase 2 / physiology
Cyclooxygenase 2 Inhibitors / adverse effects
Cyclooxygenase 2 Inhibitors / therapeutic use*
Forecasting
Humans
Urologic Diseases / drug therapy*
Urologic Diseases / etiology

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Cyclooxygenase 2